Photobiomodulation for Concussions: the Use of the ImPACT® Test as an Assessment Tool

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

March 26, 2021

Primary Completion Date

March 29, 2021

Study Completion Date

March 29, 2021

Conditions
Mild Traumatic Brain Injury
Interventions
DEVICE

BIOFLEX DUO+

"* Data scores will be collected for patients who initially underwent the Workplace Post-Injury 1 test of the ImPACT® test system prior to PBM treatment.~* Patients were treated with photobiomodulation using the BIOFLEX® DUO+ system that utilized a 180 bulb Light Emitting Diode (LED) array followed by laser probes. Both delivery methods were applied to the cervical spine and the cranium, and both entailed the use of red light at 660 nm wavelength and near-infrared light at 830-840 nm wavelength. Treatment is provided three times per week on alternating days with weekends off for 4 weeks for a total of 12 treatments utilizing Health Canada approved device specific protocol guidelines for treatment of the cervical spine.~* Data scores will be collected for a second ImPACT® test using the Workplace Post-Injury 2 test.~* Results of the Post-Injury 1 test and the Post-Injury 2 test will be compared."

Trial Locations (1)

M8W 4W3

Meditech Rehabilitation Centre, Toronto

All Listed Sponsors
lead

Meditech Rehabilitation Centre

OTHER

NCT04823507 - Photobiomodulation for Concussions: the Use of the ImPACT® Test as an Assessment Tool | Biotech Hunter | Biotech Hunter